St. Jude Medical Earnings: Here’s Why Investors are Bidding Down Shares Now

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

St. Jude Medical Inc. (NYSE:STJ) delivered a profit and beat Wall Street’s expectations, AND met the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 1.34%.

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

St. Jude Medical Inc. Earnings Cheat Sheet

Results: Net income decreased -4% to $120 million (92 cents per diluted share) in the quarter versus a net gain of $125 million in the year-earlier quarter.

Revenue: Decreased 2.62% to $1.37 billion from the year-earlier quarter.

Actual vs. Wall St. Expectations: St. Jude Medical Inc. reported adjusted net income of 92 cents per share. By that measure, the company beat the mean analyst estimate of $0.9. It met the average revenue estimate of $1.37 billion.

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business